A Pilot Study, to Evaluate the Safety and Efficacy of Topically Applied Onabotulinum Toxin A Delivered through a Novel Iontophoresis Device in Subjects with Axillary Hyperhidrosis

Main Article Content

Mark S Nestor
Haowei Han
Anita Gade
Francesca Ceci
Alec Lawson
Austin Dunn
Faraz Yousefian
Ciaran Smythe


hyperhidrosis, pilot study, safety, efficacy, topical, onabotulinum toxin A, iontophoresis


1. Doolittle, J., Walker, P., Mills, T. & Thurston, J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch. Dermatol.
Res. 308, 743–749 (2016)

2. McLenon, J. & Rogers, M. A. M. The fear of needles: A systematic review and meta-analysis. J. Adv. Nurs. 75, 30–42 (2019)

3. Naumann, M. & Lowe, N. J. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group,
double blind, placebo controlled trial. BMJ 323, 596 (2001).

Most read articles by the same author(s)